United States Parkinsons Disease Drug Market Report 2018

  • ID:PD000694
  • January 2018
  • QY Research
                          

The United States Parkinsons Disease Drug market research report is the study prepared by analysts, which contain a detailed analysis of drivers, restraints, and opportunities along with their impact on the Parkinsons Disease Drug market growth. This research report will assist in being relevant and future-oriented, while improving decision-making capabilities and reducing market risk. It is an excellent way to find the best market or target demographic for a product or service.

The report gives detailed overview of the products and segments the market as per application/ type/ regions/ end user (as applicable). The study evaluates the United States market on the basis of current and past sales, revenue, capacity, and production status. The future outlook and prospects are then derived with the help of industry experts.

Furthermore, the research report also helps to understand the comprehensive profiles of the key players in the market and in-depth view of the competitive landscape worldwide.

In this report, the United States Parkinson's Disease Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest

with sales (volume), revenue (value), market share and growth rate of Parkinson's Disease Drug in these regions, from 2012 to 2022 (forecast).

United States Parkinson's Disease Drug market competition by top manufacturers/players, with Parkinson's Disease Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Merck
  • Akorn
  • GSK
  • Novartis
  • Boehringer Ingelheim
  • Teva Pharmaceutical
  • Abbvie
  • Kyowa Hakko Kirin Pharma
  • Astellas Pharma
  • Desitin Arzneimittel
  • Endo Pharmaceuticals
  • F.Hoffmann-La Roche
  • H.Lundbeck
  • Valeant
  • Apokyn
  • Orion
  • Stada Arzneimittel
  • US WorldMeds
  • Valeant Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Sinemet-CR
  • Trastal
  • Madopar
  • COMT Inhibitor
  • Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Under 40 Years Old
  • 40-65 Years Old
  • Above 65 Years Old

Table of Contents-Sanpshot
1 Industry Overview
2 United States Market Competition by Players/Suppliers
3 United States Industry Sales (Volume) and Revenue (Value) by Region (2018-2023)
4 United States Industry Sales (Volume) and Revenue (Value) by Type (Product Category) (2018-2023)
5 United States Industry Sales (Volume) by Application (2018-2023)
6 United States Industry Players/Suppliers Profiles and Sales Data
7 Industry Manufacturing Cost Analysis
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
10 Market Effect Factors Analysis
11 United States Market Size (Value and Volume) Forecast (2018-2025)
12 Research Findings and Conclusion
13 Appendix

Table of Contents - Guidelines
 
United States Parkinson's Disease Drug Market Report 2017
1 Parkinson's Disease Drug Overview
1.1 Product Overview and Scope
1.2 Classification  by Product Category
1.2.1 United States Parkinson's Disease Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Parkinson's Disease Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Sinemet-CR
1.2.4 Trastal
1.2.5 Madopar
1.2.6 COMT Inhibitor
1.2.7 Other
1.3 United States Parkinson's Disease Drug Market by Application/End Users
1.3.1 United States Parkinson's Disease Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 United States Parkinson's Disease Drug Market by Region
1.4.1 United States Parkinson's Disease Drug Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Parkinson's Disease Drug Status and Prospect (2012-2022)
1.4.3 Southwest Parkinson's Disease Drug Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Parkinson's Disease Drug Status and Prospect (2012-2022)
1.4.5 New England Parkinson's Disease Drug Status and Prospect (2012-2022)
1.4.6 The South Parkinson's Disease Drug Status and Prospect (2012-2022)
1.4.7 The Midwest Parkinson's Disease Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume)  (2012-2022)
1.5.1 United States Parkinson's Disease Drug Sales and Growth Rate (2012-2022)
1.5.2 United States Parkinson's Disease Drug Revenue and Growth Rate (2012-2022)
 
2 United States Parkinson's Disease Drug Market Competition by Players/Suppliers
2.1 United States Parkinson's Disease Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Parkinson's Disease Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Parkinson's Disease Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Parkinson's Disease Drug Market Competitive Situation and Trends
2.4.1 United States Parkinson's Disease Drug Market Concentration Rate
2.4.2 United States Parkinson's Disease Drug Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Parkinson's Disease Drug Manufacturing Base Distribution, Sales Area, Product Type
 
3 United States Parkinson's Disease Drug Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Parkinson's Disease Drug Sales and Market Share by Region (2012-2017)
3.2 United States Parkinson's Disease Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Parkinson's Disease Drug Price by Region (2012-2017)
 
4 United States Parkinson's Disease Drug Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Parkinson's Disease Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Parkinson's Disease Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Parkinson's Disease Drug Price by Type (2012-2017)
4.4 United States Parkinson's Disease Drug Sales Growth Rate by Type (2012-2017)
 
5 United States Parkinson's Disease Drug Sales (Volume) by Application (2012-2017)
5.1 United States Parkinson's Disease Drug Sales and Market Share by Application (2012-2017)
5.2 United States Parkinson's Disease Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
 
6 United States Parkinson's Disease Drug Players/Suppliers Profiles and Sales Data
6.1 Merck
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Parkinson's Disease Drug Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Merck Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Akorn
6.2.2 Parkinson's Disease Drug Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Akorn Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 GSK
6.3.2 Parkinson's Disease Drug Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 GSK Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Novartis
6.4.2 Parkinson's Disease Drug Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Novartis Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Boehringer Ingelheim
6.5.2 Parkinson's Disease Drug Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Boehringer Ingelheim Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Teva Pharmaceutical
6.6.2 Parkinson's Disease Drug Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Teva Pharmaceutical Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Abbvie
6.7.2 Parkinson's Disease Drug Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Abbvie Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Kyowa Hakko Kirin Pharma
6.8.2 Parkinson's Disease Drug Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Astellas Pharma
6.9.2 Parkinson's Disease Drug Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Astellas Pharma Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Desitin Arzneimittel
6.10.2 Parkinson's Disease Drug Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Desitin Arzneimittel Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Endo Pharmaceuticals
6.12 F.Hoffmann-La Roche
6.13 H.Lundbeck
6.14 Valeant
6.15 Apokyn
6.16 Orion
6.17 Stada Arzneimittel
6.18 US WorldMeds
6.19 Valeant Pharmaceuticals
 
7 Parkinson's Disease Drug Manufacturing Cost Analysis
7.1 Parkinson's Disease Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis
 
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Parkinson's Disease Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources  Major Manufacturers in 2016
8.4 Downstream Buyers
 
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
 
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
 
11 United States Parkinson's Disease Drug Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Parkinson's Disease Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Parkinson's Disease Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Parkinson's Disease Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Parkinson's Disease Drug Sales Volume Forecast by Region (2017-2022)
 
12 Research Findings and Conclusion
 
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
 
Figure Product Picture of Parkinson's Disease Drug
Figure United States Parkinson's Disease Drug Market Size (K Units) by Type (2012-2022)
Figure United States Parkinson's Disease Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Sinemet-CR Product Picture
Figure Trastal Product Picture
Figure Madopar Product Picture
Figure COMT Inhibitor Product Picture
Figure Other Product Picture
Figure United States Parkinson's Disease Drug Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Parkinson's Disease Drug by Application in 2016
Figure Under 40 Years Old Examples
Table Key Downstream Customer in Under 40 Years Old
Figure 40-65 Years Old Examples
Table Key Downstream Customer in 40-65 Years Old
Figure Above 65 Years Old Examples
Table Key Downstream Customer in Above 65 Years Old
Figure United States Parkinson's Disease Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Parkinson's Disease Drug Sales (K Units) and Growth Rate (2012-2022)
Figure United States Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Parkinson's Disease Drug Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Parkinson's Disease Drug Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Parkinson's Disease Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Parkinson's Disease Drug Sales Share by Players/Suppliers
Figure 2017 United States Parkinson's Disease Drug Sales Share by Players/Suppliers
Figure United States Parkinson's Disease Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Parkinson's Disease Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Parkinson's Disease Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Parkinson's Disease Drug Revenue Share by Players/Suppliers
Figure 2017 United States Parkinson's Disease Drug Revenue Share by Players/Suppliers
Table United States Market Parkinson's Disease Drug Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Parkinson's Disease Drug Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Parkinson's Disease Drug Market Share of Top 3 Players/Suppliers
Figure United States Parkinson's Disease Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Parkinson's Disease Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Parkinson's Disease Drug Product Category
Table United States Parkinson's Disease Drug Sales (K Units) by Region (2012-2017)
Table United States Parkinson's Disease Drug Sales Share by Region (2012-2017)
Figure United States Parkinson's Disease Drug Sales Share by Region (2012-2017)
Figure United States Parkinson's Disease Drug Sales Market Share by Region in 2016
Table United States Parkinson's Disease Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Parkinson's Disease Drug Revenue Share by Region (2012-2017)
Figure United States Parkinson's Disease Drug Revenue Market Share by Region (2012-2017)
Figure United States Parkinson's Disease Drug Revenue Market Share by Region in 2016
Table United States Parkinson's Disease Drug Price (USD/Unit) by Region (2012-2017)
Table United States Parkinson's Disease Drug Sales (K Units) by Type (2012-2017)
Table United States Parkinson's Disease Drug Sales Share by Type (2012-2017)
Figure United States Parkinson's Disease Drug Sales Share by Type (2012-2017)
Figure United States Parkinson's Disease Drug Sales Market Share by Type in 2016
Table United States Parkinson's Disease Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Parkinson's Disease Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Parkinson's Disease Drug by Type (2012-2017)
Figure Revenue Market Share of Parkinson's Disease Drug by Type in 2016
Table United States Parkinson's Disease Drug Price (USD/Unit) by Types (2012-2017)
Figure United States Parkinson's Disease Drug Sales Growth Rate by Type (2012-2017)
Table United States Parkinson's Disease Drug Sales (K Units) by Application (2012-2017)
Table United States Parkinson's Disease Drug Sales Market Share by Application (2012-2017)
Figure United States Parkinson's Disease Drug Sales Market Share by Application (2012-2017)
Figure United States Parkinson's Disease Drug Sales Market Share by Application in 2016
Table United States Parkinson's Disease Drug Sales Growth Rate by Application (2012-2017)
Figure United States Parkinson's Disease Drug Sales Growth Rate by Application (2012-2017)
Table Merck Basic Information List
Table Merck Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Parkinson's Disease Drug Sales Growth Rate (2012-2017)
Figure Merck Parkinson's Disease Drug Sales Market Share in United States (2012-2017)
Figure Merck Parkinson's Disease Drug Revenue Market Share in United States (2012-2017)
Table Akorn Basic Information List
Table Akorn Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Akorn Parkinson's Disease Drug Sales Growth Rate (2012-2017)
Figure Akorn Parkinson's Disease Drug Sales Market Share in United States (2012-2017)
Figure Akorn Parkinson's Disease Drug Revenue Market Share in United States (2012-2017)
Table GSK Basic Information List
Table GSK Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK Parkinson's Disease Drug Sales Growth Rate (2012-2017)
Figure GSK Parkinson's Disease Drug Sales Market Share in United States (2012-2017)
Figure GSK Parkinson's Disease Drug Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Parkinson's Disease Drug Sales Growth Rate (2012-2017)
Figure Novartis Parkinson's Disease Drug Sales Market Share in United States (2012-2017)
Figure Novartis Parkinson's Disease Drug Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Parkinson's Disease Drug Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim Parkinson's Disease Drug Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim Parkinson's Disease Drug Revenue Market Share in United States (2012-2017)
Table Teva Pharmaceutical Basic Information List
Table Teva Pharmaceutical Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Parkinson's Disease Drug Sales Growth Rate (2012-2017)
Figure Teva Pharmaceutical Parkinson's Disease Drug Sales Market Share in United States (2012-2017)
Figure Teva Pharmaceutical Parkinson's Disease Drug Revenue Market Share in United States (2012-2017)
Table Abbvie Basic Information List
Table Abbvie Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbvie Parkinson's Disease Drug Sales Growth Rate (2012-2017)
Figure Abbvie Parkinson's Disease Drug Sales Market Share in United States (2012-2017)
Figure Abbvie Parkinson's Disease Drug Revenue Market Share in United States (2012-2017)
Table Kyowa Hakko Kirin Pharma Basic Information List
Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales Growth Rate (2012-2017)
Figure Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales Market Share in United States (2012-2017)
Figure Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Revenue Market Share in United States (2012-2017)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Astellas Pharma Parkinson's Disease Drug Sales Growth Rate (2012-2017)
Figure Astellas Pharma Parkinson's Disease Drug Sales Market Share in United States (2012-2017)
Figure Astellas Pharma Parkinson's Disease Drug Revenue Market Share in United States (2012-2017)
Table Desitin Arzneimittel Basic Information List
Table Desitin Arzneimittel Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Desitin Arzneimittel Parkinson's Disease Drug Sales Growth Rate (2012-2017)
Figure Desitin Arzneimittel Parkinson's Disease Drug Sales Market Share in United States (2012-2017)
Figure Desitin Arzneimittel Parkinson's Disease Drug Revenue Market Share in United States (2012-2017)
Table Endo Pharmaceuticals Basic Information List
Table F.Hoffmann-La Roche Basic Information List
Table H.Lundbeck Basic Information List
Table Valeant Basic Information List
Table Apokyn Basic Information List
Table Orion Basic Information List
Table Stada Arzneimittel Basic Information List
Table US WorldMeds Basic Information List
Table Valeant Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Parkinson's Disease Drug
Figure Manufacturing Process Analysis of Parkinson's Disease Drug
Figure Parkinson's Disease Drug Industrial Chain Analysis
Table Raw Materials Sources of Parkinson's Disease Drug Major Players/Suppliers in 2016
Table Major Buyers of Parkinson's Disease Drug
Table Distributors/Traders List
Figure United States Parkinson's Disease Drug Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Parkinson's Disease Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Parkinson's Disease Drug Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Parkinson's Disease Drug Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Parkinson's Disease Drug Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Parkinson's Disease Drug Sales Volume (K Units) Forecast by Type in 2022
Table United States Parkinson's Disease Drug Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Parkinson's Disease Drug Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Parkinson's Disease Drug Sales Volume (K Units) Forecast by Application in 2022
Table United States Parkinson's Disease Drug Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Parkinson's Disease Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Parkinson's Disease Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Parkinson's Disease Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Research Report 2017

The Global Tigecycline Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost  read more..


Global Risperidone Market Research Report 2017

The Global Risperidone Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost  read more..


Global Caffeine Market Research Report 2017

The Global Caffeine Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost structure,  read more..


Global Rabies Vaccine Market Research Report 2017

The Global Rabies Vaccine Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost  read more..


Global Radiopharmaceuticals Market Research Report 2017

The Radiopharmaceuticals Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost  read more..


Global Neurorehabilitation System Market Research Report

Neurorehabilitation system is as innovative technological solution to monitor and review the activity of nervous systems. It is a relatively new method  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The global molecular biology kits and reagents market is expected to grow at a CAGR of ~7% from 2013 to 2018. A number of factors such as rise in  read more..


Global High Acuity Care Information Systems Market Research Report

The global high acuity care information systems market is expected to grow at a CAGR of ~4% from 2013 to 2018. A number of factors such as growing focus  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

Cancers of skin tissues are one of the major types of cancers in the world. In recent years, more than 40% of all cancers in the U.S. have been skin  read more..